Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
CHINA OILFIELD
02883
5
CNOOC
00883
CA Stock MarketDetailed Quotes
Cardiol Therapeutics Inc (CRDL)
- 1.890
- +0.030+1.61%
15min DelayMarket Closed Apr 24 16:00 ET
211.08MMarket Cap-4.85P/E (TTM)
1.960High1.830Low107.00KVolume1.890Open1.860Prev Close203.93KTurnover2.33052wk High0.11%Turnover Ratio111.68MShares1.22552wk Low-0.39EPS TTM182.36MFloat Cap8.490Historical HighLossP/E (Static)96.49MShs Float0.610Historical Low-0.39EPS LYR6.99%Range %--Dividend TTM11.81P/B1Lot Size--Div Yield TTM
Cardiol Therapeutics Inc (CRDL) Income Statement
Quarterly+Annual
YOY
| (FY)Dec 31, 2025 | (Q4)Dec 31, 2025 | (Q3)Sep 30, 2025 | (Q2)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating revenue | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
| Cost of revenue | ||||||||||
| Gross profit | ||||||||||
| Operating expense | -14.80%34.32M | -19.61%8.03M | -28.01%10.18M | -0.84%7.68M | 0.28%8.43M | 35.22%40.28M | 24.42%9.99M | 84.70%14.14M | 22.59%7.74M | 7.95%8.41M |
| Selling and administrative expenses | -22.00%20.2M | -7.88%5.26M | -47.31%5.37M | -1.02%4.92M | -7.45%4.65M | 66.38%25.89M | 43.22%5.71M | 100.60%10.19M | 75.29%4.97M | 37.24%5.02M |
| -General and administrative expense | -22.00%20.2M | -7.88%5.26M | -47.31%5.37M | -1.02%4.92M | -7.45%4.65M | 66.38%25.89M | 43.22%5.71M | 100.60%10.19M | 75.29%4.97M | 37.24%5.02M |
| Research and development costs | 0.05%14.02M | -35.14%2.74M | 27.62%4.79M | 0.81%2.73M | 13.08%3.76M | -1.49%14.01M | 4.66%4.23M | 45.56%3.75M | -22.12%2.71M | -19.50%3.32M |
| Depreciation amortization depletion | -72.67%101.98K | -46.43%25.98K | -87.29%25.55K | -58.86%25.47K | -59.45%24.99K | --373.11K | --48.49K | --201.09K | --61.91K | --61.62K |
| -Depreciation and amortization | -72.67%101.98K | -46.43%25.98K | -87.29%25.55K | -58.86%25.47K | -59.45%24.99K | --373.11K | --48.49K | --201.09K | --61.91K | --61.62K |
| Operating profit | 14.80%-34.32M | 19.61%-8.03M | 28.01%-10.18M | 0.84%-7.68M | -0.28%-8.43M | -35.22%-40.28M | -24.42%-9.99M | -84.70%-14.14M | -22.59%-7.74M | -7.95%-8.41M |
| Net non-operating interest income (expenses) | -39.13%726.4K | -42.89%175.21K | -39.44%122.26K | -41.23%180.67K | -34.20%248.27K | -41.46%1.19M | -31.57%306.78K | -60.84%201.86K | -41.86%307.41K | -30.89%377.29K |
| Non-operating interest income | -39.13%726.4K | -42.89%175.21K | -39.44%122.26K | -41.23%180.67K | -34.20%248.27K | -41.46%1.19M | -31.57%306.78K | -60.84%201.86K | -41.86%307.41K | -30.89%377.29K |
| Other net income (expenses) | -109.52%-228.98K | -57.24%643.2K | -92.27%93.56K | -201.88%-858.88K | 90.72%-106.86K | 731.08%2.41M | 2,762.92%1.5M | -0.01%1.21M | 150.01%843.06K | -863.19%-1.15M |
| Gain on sale of security | -109.63%-228.98K | -57.24%643.2K | -92.27%93.56K | -201.88%-858.88K | 90.94%-106.86K | 547.80%2.38M | 2,762.92%1.5M | 14.11%1.21M | 150.01%843.06K | -881.89%-1.18M |
| Other non-operating income (expenses) | ---- | ---- | ---- | ---- | ---- | -81.15%28.22K | --0 | ---- | ---- | --28.22K |
| Income before tax | 7.79%-33.82M | 11.81%-7.21M | 21.72%-9.96M | -26.76%-8.35M | 9.72%-8.29M | -30.39%-36.68M | -7.09%-8.18M | -114.64%-12.73M | 11.79%-6.59M | -29.49%-9.18M |
| Income tax | ||||||||||
| Earnings from equity interest net of tax | ||||||||||
| Net income | 7.79%-33.82M | 11.81%-7.21M | 21.72%-9.96M | -26.76%-8.35M | 9.72%-8.29M | -30.39%-36.68M | -7.09%-8.18M | -114.64%-12.73M | 11.79%-6.59M | -29.49%-9.18M |
| Net income continuous operations | 7.79%-33.82M | 11.81%-7.21M | 21.72%-9.96M | -26.76%-8.35M | 9.72%-8.29M | -30.39%-36.68M | -7.09%-8.18M | -114.64%-12.73M | 11.79%-6.59M | -29.49%-9.18M |
| Noncontrolling interests | ||||||||||
| Net income attributable to the company | 7.79%-33.82M | 11.81%-7.21M | 21.72%-9.96M | -26.76%-8.35M | 9.72%-8.29M | -30.39%-36.68M | -7.09%-8.18M | -114.64%-12.73M | 11.79%-6.59M | -29.49%-9.18M |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | ||||||||||
| Net income attributable to common stockholders | 7.79%-33.82M | 11.81%-7.21M | 21.72%-9.96M | -26.76%-8.35M | 9.72%-8.29M | -30.39%-36.68M | -7.09%-8.18M | -114.64%-12.73M | 11.79%-6.59M | -29.49%-9.18M |
| Diluted earnings per share | 23.53%-0.39 | 22.22%-0.07 | 33.33%-0.12 | 0.00%-0.1 | 28.57%-0.1 | -15.91%-0.51 | 25.00%-0.09 | -100.00%-0.18 | 16.67%-0.1 | -27.27%-0.14 |
| Basic earnings per share | 23.53%-0.39 | 22.22%-0.07 | 33.33%-0.12 | 0.00%-0.1 | 28.57%-0.1 | -15.91%-0.51 | 25.00%-0.09 | -100.00%-0.18 | 16.67%-0.1 | -27.27%-0.14 |
| Dividend per share | ||||||||||
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Market Insights
Hot Topics Hot Topics
Middle East conflict spreads to the stock market! How should investors respond?
Signs of restarting the second round of US-Iran talks have emerged. According to reports, Iran's foreign minister arrived in Pakistan on Fri
牛牛課堂
Mar 4 17:09
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
牛牛課堂
Mar 18 18:18
Hormuz, Term Structure and USO: Navigating the Energy Storm